[Continuation of ACEI/ARB treatment in patients diagnosed with COVID-19].

Ávila Cabreja, José Alejandro; García Méndez, Felicia María; Sosa González, Ismael; Zayas Fundora, Emmanuel

[Continuation of ACEI/ARB treatment in patients diagnosed with COVID-19]. / Continuación del tratamiento con IECA/ARA-II en los pacientes diagnosticados de COVID-19.

Ávila Cabreja, José Alejandro; García Méndez, Felicia María; Sosa González, Ismael; Zayas Fundora, Emmanuel.

Ávila Cabreja JA; Facultad de Ciencias Médicas Manuel Fajardo, Universidad de Ciencias Médicas de La Habana, La Habana, Cuba. Electronic address: javilacabreja@gmail.com.
García Méndez FM; Facultad de Ciencias Médicas Manuel Fajardo, Universidad de Ciencias Médicas de La Habana, La Habana, Cuba.
Sosa González I; Facultad de Ciencias Médicas Manuel Fajardo, Universidad de Ciencias Médicas de La Habana, La Habana, Cuba.
Zayas Fundora E; Facultad de Ciencias Médicas Manuel Fajardo, Universidad de Ciencias Médicas de La Habana, La Habana, Cuba.

Aten Primaria ; 53(6): 102068, 2021.

Article in Spanish | MEDLINE | ID: covidwho-1191224

Subject(s)

Angiotensin Receptor Antagonists/adverse effects; Angiotensin-Converting Enzyme Inhibitors/adverse effects; COVID-19/etiology; Withholding Treatment; Angiotensin Receptor Antagonists/administration & dosage; Angiotensin-Converting Enzyme Inhibitors/administration & dosage; COVID-19/diagnosis; COVID-19/mortality; COVID-19/therapy; Drug Administration Schedule; Humans; Risk Factors; Severity of Illness Index; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Withholding Treatment / Angiotensin Receptor Antagonists / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: Spanish Journal: Aten Primaria Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google